Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B.

Choe JY, Ko JS, Choe BH, Kim JE, Kang B, Lee KJ, Yang HR.

J Korean Med Sci. 2018 Jan 8;33(2):e11. doi: 10.3346/jkms.2018.33.e11.

2.

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.

Kwon MJ, Kim KC, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Choe JY, Lee HK, Kang HS, Min KW.

Oncotarget. 2017 Jul 19;8(47):82399-82414. doi: 10.18632/oncotarget.19390. eCollection 2017 Oct 10.

3.

Descending necrotizing mediastinitis after a trigger point injection.

Choe JY, Kim JK, Lee DE, Seo KS, Park JB, Lee MJ, Ryoo HW, Ahn JY, Moon S.

Clin Exp Emerg Med. 2017 Sep 30;4(3):182-185. doi: 10.15441/ceem.16.197. eCollection 2017 Sep.

4.

Prevalence and Epidemiological Characteristics of Endoscopically Proven Reflux Esophagitis in Children in Korea.

Yang A, Kang B, Choe JY, Kim HS, Kim K, Choe YH.

Pediatr Gastroenterol Hepatol Nutr. 2017 Sep;20(3):160-166. doi: 10.5223/pghn.2017.20.3.160. Epub 2017 Sep 26.

5.

Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators.

Tripp J, Essl C, Iancu CV, Boles E, Choe JY, Oreb M.

Sci Rep. 2017 Jul 24;7(1):6197. doi: 10.1038/s41598-017-06262-4.

6.

Ileocolic intussusception caused by a lipoma in an adult.

Lee DE, Choe JY.

World J Clin Cases. 2017 Jun 16;5(6):254-257. doi: 10.12998/wjcc.v5.i6.254.

7.

Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial.

Yoo DH, Suh CH, Shim SC, Jeka S, Molina FFC, Hrycaj P, Wiland P, Lee EY, Medina-Rodriguez FG, Shesternya P, Radominski S, Stanislav M, Kovalenko V, Sheen DH, Myasoutova L, Lim MJ, Choe JY, Lee SJ, Lee SY, Kim SH, Park W.

BioDrugs. 2017 Aug;31(4):357-367. doi: 10.1007/s40259-017-0232-7.

8.

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis.

Park W, Suh CH, Shim SC, Molina FFC, Jeka S, Medina-Rodriguez FG, Hrycaj P, Wiland P, Lee EY, Shesternya P, Kovalenko V, Myasoutova L, Stanislav M, Radominski S, Lim MJ, Choe JY, Lee SJ, Lee SY, Kim SH, Yoo DH.

BioDrugs. 2017 Aug;31(4):369-377. doi: 10.1007/s40259-017-0233-6.

9.

Differences in salicylic acid glucose conjugations by UGT74F1 and UGT74F2 from Arabidopsis thaliana.

George Thompson AM, Iancu CV, Neet KE, Dean JV, Choe JY.

Sci Rep. 2017 Apr 20;7:46629. doi: 10.1038/srep46629.

10.
11.

Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis.

Sung YK, Cho SK, Kim D, Yoon BY, Choi CB, Cha HS, Choe JY, Chung WT, Hong SJ, Jun JB, Kang YM, Kim J, Kim TH, Kim TJ, Koh E, Lee CK, Lee J, Lee SS, Lee SW, Lee HS, Lee YA, Park SH, Yoo DH, Yoo WH, Bae SC; KORONA Investigators.

J Korean Med Sci. 2016 Dec;31(12):1907-1913. doi: 10.3346/jkms.2016.31.12.1907.

12.

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis.

Yoo DH, Suh CH, Shim SC, Jeka S, Cons-Molina FF, Hrycaj P, Wiland P, Lee EY, Medina-Rodriguez FG, Shesternya P, Radominski S, Stanislav M, Kovalenko V, Sheen DH, Myasoutova L, Lim MJ, Choe JY, Lee SJ, Lee SY, Kwon TS, Park W.

Ann Rheum Dis. 2017 Mar;76(3):566-570. doi: 10.1136/annrheumdis-2016-209540. Epub 2016 Sep 13.

13.

Impact of early diagnosis on functional disability in rheumatoid arthritis.

Kim D, Choi CB, Lee J, Cho SK, Won S, Bang SY, Cha HS, Choe JY, Chung WT, Hong SJ, Jun JB, Jung YO, Kim J, Kim SK, Kim TH, Kim TJ, Koh E, Lee HS, Lee J, Lee J, Lee SH, Lee SS, Lee SW, Shim SC, Yoo DH, Yoon BY, Sung YK, Bae SC; KORONA investigators.

Korean J Intern Med. 2017 Jul;32(4):738-746. doi: 10.3904/kjim.2015.364. Epub 2016 Sep 13.

14.

Genetic Association for P2X7R rs3751142 and CARD8 rs2043211 Polymorphisms for Susceptibility of Gout in Korean Men: Multi-Center Study.

Lee SW, Lee SS, Oh DH, Park DJ, Kim HS, Choi JR, Chae SC, Yun KJ, Chung WT, Choe JY, Kim SK.

J Korean Med Sci. 2016 Oct;31(10):1566-70. doi: 10.3346/jkms.2016.31.10.1566.

15.

Assembly of Bak homodimers into higher order homooligomers in the mitochondrial apoptotic pore.

Mandal T, Shin S, Aluvila S, Chen HC, Grieve C, Choe JY, Cheng EH, Hustedt EJ, Oh KJ.

Sci Rep. 2016 Aug 4;6:30763. doi: 10.1038/srep30763.

16.
17.

Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis.

Kim K, Bang SY, Ikari K, Yoo DH, Cho SK, Choi CB, Sung YK, Kim TH, Jun JB, Kang YM, Suh CH, Shim SC, Lee SS, Lee J, Chung WT, Kim SK, Choe JY, Momohara S, Taniguchi A, Yamanaka H, Nath SK, Lee HS, Bae SC.

Sci Rep. 2016 Jun 8;6:27563. doi: 10.1038/srep27563.

18.

Soft, thin skin-mounted power management systems and their use in wireless thermography.

Lee JW, Xu R, Lee S, Jang KI, Yang Y, Banks A, Yu KJ, Kim J, Xu S, Ma S, Jang SW, Won P, Li Y, Kim BH, Choe JY, Huh S, Kwon YH, Huang Y, Paik U, Rogers JA.

Proc Natl Acad Sci U S A. 2016 May 31;113(22):6131-6. doi: 10.1073/pnas.1605720113. Epub 2016 May 16.

19.

Discovery of a specific inhibitor of human GLUT5 by virtual screening and in vitro transport evaluation.

George Thompson AM, Ursu O, Babkin P, Iancu CV, Whang A, Oprea TI, Choe JY.

Sci Rep. 2016 Apr 14;6:24240. doi: 10.1038/srep24240.

20.

Hxt13, Hxt15, Hxt16 and Hxt17 from Saccharomyces cerevisiae represent a novel type of polyol transporters.

Jordan P, Choe JY, Boles E, Oreb M.

Sci Rep. 2016 Mar 21;6:23502. doi: 10.1038/srep23502.

Supplemental Content

Loading ...
Support Center